IRIS
BURLONE, MICHELA Emma
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.250
NA - Nord America 1.187
AS - Asia 769
SA - Sud America 145
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.377
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.153
IE - Irlanda 300
SG - Singapore 237
DE - Germania 185
IT - Italia 165
CN - Cina 160
SE - Svezia 144
BR - Brasile 118
HK - Hong Kong 118
UA - Ucraina 103
FR - Francia 97
VN - Vietnam 89
RU - Federazione Russa 82
IN - India 78
FI - Finlandia 50
GB - Regno Unito 38
KR - Corea 25
AT - Austria 22
CA - Canada 20
ID - Indonesia 18
BE - Belgio 15
BD - Bangladesh 12
MX - Messico 12
PL - Polonia 12
BJ - Benin 11
NL - Olanda 10
AR - Argentina 9
CZ - Repubblica Ceca 8
ES - Italia 8
TR - Turchia 7
EC - Ecuador 6
IR - Iran 6
ZA - Sudafrica 6
KE - Kenya 5
JP - Giappone 4
CH - Svizzera 3
CL - Cile 3
IQ - Iraq 3
VE - Venezuela 3
AZ - Azerbaigian 2
EU - Europa 2
PE - Perù 2
PT - Portogallo 2
PY - Paraguay 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
CO - Colombia 1
DO - Repubblica Dominicana 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MT - Malta 1
NP - Nepal 1
RO - Romania 1
TN - Tunisia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.377
Salva come PNG Salva come JPEG
Città #
Dublin 297
Jacksonville 175
Hong Kong 118
Chandler 89
Singapore 85
Ashburn 82
Dearborn 82
Beijing 72
Ann Arbor 67
Wilmington 54
Los Angeles 39
Piemonte 39
Novara 36
Princeton 34
Lawrence 33
Munich 33
Moscow 27
Buffalo 25
Seoul 25
Ho Chi Minh City 21
Hanoi 18
San Mateo 18
São Paulo 17
Brussels 15
Andover 14
Santa Clara 14
Milan 13
New York 13
Nuremberg 13
Jakarta 12
Cotonou 11
Frankfurt am Main 11
Houston 11
Denver 10
Dong Ket 10
Helsinki 10
Brooklyn 9
Nanjing 9
Atlanta 8
Brno 8
Dallas 8
Bremen 7
Hefei 7
Phoenix 7
Seattle 7
Turin 7
Amsterdam 6
Da Nang 6
Mumbai 6
Orem 6
Poplar 6
Redondo Beach 6
San Jose 6
Tianjin 6
Warsaw 6
Ankara 5
Augusta 5
Bexley 5
Falkenstein 5
Jinan 5
Kunming 5
Nairobi 5
Porto Alegre 5
Stockholm 5
Toronto 5
Biên Hòa 4
Boardman 4
Boston 4
Chicago 4
Curitiba 4
Johannesburg 4
Leawood 4
London 4
Manchester 4
Monmouth Junction 4
Montreal 4
Rome 4
Tokyo 4
Turku 4
Vienna 4
Woodbridge 4
Brasília 3
Calgary 3
Cassano Magnago 3
Chennai 3
Dhaka 3
Fairfield 3
Hải Dương 3
Kraków 3
Magenta 3
Mexico City 3
Norwalk 3
Querétaro 3
Quito 3
Ribeirão Preto 3
Rio de Janeiro 3
Roubaix 3
Strasbourg 3
Ardabil 2
Baku 2
Totale 1.943
Salva come PNG Salva come JPEG
Nome #
On-target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi-centre, prospective study 136
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD) 131
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 123
Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib 111
Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients 110
Red cell distribution width and platelet count as biomarkers of pulmonary arterial hypertension in patients with connective tissue disorders 107
Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis 105
Influence of age on sex-related differences among patients with hepatitis C. 103
Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma 102
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 100
Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma 98
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma 93
[Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: final analysis of GIDEON study in Italy] 93
Recent advances in HCV entry 91
IL28B Polymorphism, Blood Interferon-alpha Concentration, and Disease Stage of HCV Mono-infected and HCV-HIV Co-infected Patients. 90
Interferon alpha concentrations in blood and peritoneal fluid during treatment for hepatitis C 89
Cardiac dysfunction as an early predictor of portal hypertension in chronic hepatitis C 89
Liver stiffness, not fat liver content, predicts the length of QTc interval in patients with chronic liver disease 89
17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon 88
Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease 88
Fibrosis Progression in HCV Carriers with Mild Hepatitis Who Possess the High-Repetition Variant of the DRD4 Gene, a Genetic Marker for Binge-Drinking and Risk-Seeking Behavior: A Longitudinal Study. 86
Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naïve patients with chronic lymphocytic leukemia 84
Interferon-stimulated gene pathways in the treatment of viral hepatitis 83
HBV AND LYMPHOMAGENESIS: NOVEL INSIGHTS INTO AN OCCULT RELATIONSHIP 79
HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment 78
Influence of angiotensin-converting enzyme I/D gene polymorphism on clinical and histological correlates of chronic hepatitis C 74
Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study 74
The albumin–bilirubin grade improves hepatic reserve estimation post-sorafenib failure: implications for drug development 73
Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment 70
Hepatitis C virus cell entry: role of lipoproteins and cellular receptors. 69
Direct antivirals and cognitive impairment in hepatitis C: a clinical-neurophysiologic study 67
GENETIC POLYMORPHISM AT THE APOLIPOPROTEIN E LOCUS AFFECTS THE OUTCOME OF CHRONIC HEPATITIS B 66
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD) 65
Toxocara encephalitis presenting with autonomous nervous system involvement 65
Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progression 55
PANCREATOBILIARY REFLUX RESULTING IN PANCREATIC ASCITES AND CHOLEPERITONEUM AFTER GALLBLADDER PERFORATION 53
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma 52
Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development 50
Radioembolization vs sorafenib in locally advanced hepatocellular carcinoma with portal vein tumor thrombosis: A propensity score and Bayesian analysis 44
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma 43
From MASH to HCC: the role of Gas6/TAM receptors 38
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis 38
Totale 3.442
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.316
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.316
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021158 0 0 0 0 0 23 37 3 35 11 35 14
2021/2022234 4 13 31 18 15 2 20 12 16 22 32 49
2022/2023641 60 33 41 7 44 62 17 36 307 1 23 10
2023/2024240 24 39 21 0 35 2 42 6 1 4 27 39
2024/2025537 17 3 41 7 17 32 58 51 128 57 17 109
2025/2026900 98 91 121 321 184 85 0 0 0 0 0 0
Totale 3.442